IBJNews

Lilly's win in Evista patent case crucial, analyst says

Back to TopCommentsE-mailPrintBookmark and Share

A decision by a federal judge in Indianapolis to turn back a patent challenge to Eli Lilly and Co.’s Evista marks a major victory for the company, says an analyst who closely follows the pharmaceutical industry.

In Wednesday’s decision, U.S. District Court Judge Sarah Evans Barker ruled that Lilly’s method-of-use patents for Evista are valid through 2014, rejecting all the claims of Israel-based generic drug firm Teva Pharmaceuticals Industries Ltd.

Evista, an osteoporosis drug, generated global sales of $1 billion last year, including $700 million in the United States, and is considered a blockbuster drug.
 
“Lilly’s taken a couple of hits lately, so it would have been bad [to lose the case],” said Les Funtleyder, a health care stock analyst at New York-based Miller Tabak & Co.

Earlier this month, the company said it plans eliminate 5,500 jobs by the end of 2011 as it tries to cut $1 billion in expenses before it loses the revenue from its bestselling drug, Zyprexa.

Indianapolis-based Lilly faces the patent expiration of Zyprexa in November 2011, after which it will lose most of the drug’s $4.7 billion in annual sales to cheaper generic versions. In addition, patents will expire by 2014 on four other major Lilly drugs, including Evista.

Challenges to Lilly’s patents aren’t unusual, but disputes brought by Teva warrant serious consideration, Funtleyder said.

“I don’t think a lot of people thought there was a high probability that [Lilly] would lose, because these cases usually go in favor of the innovator,” he said. “But Teva is one of the smarter generics.”

Teva has sought to market a cheaper generic version of Evista, also known as raloxifene.

The decision wasn’t a total victory for Lilly. Barker said its patents on Evista’s particle size are invalid. Lilly said it is considering whether to appeal that part of the ruling.

The expiration date for the particle-size patents, which involve the size of the molecule used in Evista, had been 2017. If Lilly appeals the judge’s ruling, and it is successful, it could market Evista for an additional three years without a threat from generics.

“Patents provide us a limited amount of time to recoup our investments,” Lilly spokesman Mark Taylor said following the decision. “This is how we reinvest that money back into the research and development of the next generation of pharmaceuticals.”

The stock market had little reaction to the court decision. Lilly shares were down 6 cents late this morning, trading at $32.38 each.

 

ADVERTISEMENT

  • Off of Evista
    I, too, had to stop - just too expensive. Do you understand that the patent expires in March 2014? Hope so!
  • EVISTA
    I have been taking EVISTA since it has been on market in 1993 I think it is a great drug I looking forward to it going generic it is so expensive I can hardly afford it.
  • Evista
    I need Evista but had to go off it because I couldn't afford it
    • Evista
      Hoping the patent will be removed. Paying high price for 30day refills is not good. I have been taking Evista since 1993. Do not want to switch now to another drug.
      • Evista
        I will be happy to go to the pharmacy and have a cheaper co pay for Evista. I have been on this drug since 1993. Lets hope it sticks for the patent removal. I don't want to change in taking another drug.
      • evista generic
        I cannot wait until this drug is generic because it is so expensive.

        Thank you!

      Post a comment to this story

      COMMENTS POLICY
      We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
       
      You are legally responsible for what you post and your anonymity is not guaranteed.
       
      Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
       
      No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
       
      We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
       

      Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

      Sponsored by
      ADVERTISEMENT

      facebook - twitter on Facebook & Twitter

      Follow on TwitterFollow IBJ on Facebook:
      Follow on TwitterFollow IBJ's Tweets on these topics:
       
      Subscribe to IBJ
      1. Yes sir keep cashing those 300K a year checks direct to IMS, while millions disappear from the teams like Rahal's. Guess there wasn't enough ka- ching going around to keep Sarah Fisher in business without their "merger". LOL._____.Meanwhile back in Realville the series with the "best racing in the world" drew what appeared to be about 5000 live spectators ( and probably 1500 of those Target "freebies", and was beaten in the ratings by a series that reportedly consists of "parades" and aired while most people are still sleeping. That will generate those big ka-chings for sure. :-). But, hey, as long as the Speedway gets the cash who gives a damn about the teams?

      2. Welcome to PETERSON LOAN AGENCY Company (A Personalized Service for All Your Financial Needs) We, Liberal Investment Company Providers offers loan at a very low interest rate of 2%, we offer Personal loans, Debt Consolidation Loan, Venture Capital, Business Loan, Educational Loan, Home Loan, and Loan for any reason and urgent needs!. with a maximum duration of 30 years. Have you been turned down by your bank? Do you have bad credit? Do you have unpaid bills? Are you in debt? Do you need to set up a business? Worry no more as we are here to offer you a low interest loan. Our loan ranges from $5,000-USD (Five Thousand US dollars) to $50, 000,000.00.(Fifty Million US dollars). We also lend in USA DOLLARS EURO and POUNDS ! Fill in this form and forward it to our email: PETERSONLOANAGENCY@GMAIL.COM 1. Your Full names:_______ 2. Contact address:_______ 3. Country Of Residence:______ 4. Loan Amount Required:________ 5. Duration:_____ 6. Gender:_____ 7. Occupation:________ 8. Monthly Income:_______ 9. Date Of Birth:________ 10.Telephone Number:________ 11. Purpose of loan:_________ Yours In Service, MR PERRY, PETERSONLOANAGENCY@GMAIL.COM

      3. If I could actually get the prices...I would do this on my own. We need laws that force provides to publish the costs they will charge. Everyone else gives you the price in advance...except hospitals.

      4. I was under the impression that fencing is not allowed on a front yard and that on a corner, both sides are considered "front" yards, therefore can't be fenced without a variance. Also impedes the visibility for drivers at the intersection. Am I understanding this correctly? Might be why a fence was not included in the plans and a request for a variance will have to be made?.

      5. I was a big fan of Cowards and Carrots, which I got a chance to see at the show. It's currently on Kickstarter, but the designer also put out What's He Building in There last year, which got a fair amount of buzz.

      ADVERTISEMENT